Evidence map›Paper›PMID 33882699›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis.

Le Wang, Xiaozhong Guo, Xiangbo Xu, Shixue Xu, Juqiang Han, Ran Wang, Zeqi Guo, Fangfang Yi, Xingshun Qi

Open access · goldAbstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Le WangLiver Cirrhosis Study Group, Department of Gastroenterology, 74643General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, China.
Xiaozhong GuoLiver Cirrhosis Study Group, Department of Gastroenterology, 74643General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, China.
Xiangbo XuLiver Cirrhosis Study Group, Department of Gastroenterology, 74643General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, China.
Shixue XuLiver Cirrhosis Study Group, Department of Gastroenterology, 74643General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, China.
Juqiang HanInstitute of Hepatology, PLA Army General Hospital, Beijing, China.
Ran WangLiver Cirrhosis Study Group, Department of Gastroenterology, 74643General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, China.ORCID https://orcid.org/0000-0001-6137-9980
Zeqi GuoLiver Cirrhosis Study Group, Department of Gastroenterology, 74643General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, China.
Fangfang YiLiver Cirrhosis Study Group, Department of Gastroenterology, 74643General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, China.
Xingshun QiLiver Cirrhosis Study Group, Department of Gastroenterology, 74643General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, China.ORCID https://orcid.org/0000-0002-9448-6739
General Hospital of Shenyang Military Region · CNDalian Medical University · CNThe Military General Hospital of Beijing PLA · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Portal venous system thrombosis (PVST), a common complication of liver cirrhosis, is closely associated with thrombophilia. To explore the association of homocysteine (Hcy), anticardiolipin antibody (aCL), and anti-β2 glycoprotein I antibody (aβ

Indexed as

AdultAgedAged, 80 and overAntibodies, Anticardiolipinbeta 2-Glycoprotein IHomocysteineHumansLiver CirrhosisMiddle AgedVenous ThrombosisYoung AdultAntibodies, Anticardiolipinbeta 2-Glycoprotein IHomocysteineanticardiolipin antibodyanti-β2 glycoprotein I antibodyhomocysteineliver cirrhosisportal veinthrombosis

Identifiers

PMID33882699
PMCPMC8072837
OpenAlexW3156631463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.